0001951684-22-000001.txt : 20221229 0001951684-22-000001.hdr.sgml : 20221229 20221229150936 ACCESSION NUMBER: 0001951684-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221229 DATE AS OF CHANGE: 20221229 EFFECTIVENESS DATE: 20221229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RENASANT CAPITAL FUNDING CORP CENTRAL INDEX KEY: 0001951684 IRS NUMBER: 883955686 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469131 FILM NUMBER: 221498604 BUSINESS ADDRESS: STREET 1: 3328 PEACHTREE ROAD STREET 2: SUITE 150 CITY: ATLANTA STATE: GA ZIP: 30326 BUSINESS PHONE: 678-442-3981 MAIL ADDRESS: STREET 1: 3328 PEACHTREE ROAD STREET 2: SUITE 150 CITY: ATLANTA STATE: GA ZIP: 30326 D 1 primary_doc.xml X0708 D LIVE 0001951684 RENASANT CAPITAL FUNDING CORP 3328 PEACHTREE ROAD SUITE 150 ATLANTA GA GEORGIA 30326 678-442-3981 GEORGIA None None Corporation true 2022 CURTIS J. PERRY C/O RENASANT CAPITAL FUNDING CORPORATION 3328 PEACHTREE ROAD, SUITE 150 ATLANTA GA GEORGIA 30326 Executive Officer Director KENNETH E. DAVIS C/O RENASANT CAPITAL FUNDING CORPORATION 3328 PEACHTREE ROAD, SUITE 150 ATLANTA GA GEORGIA 30326 Director CHRISTOPHER TORIE C/O RENASANT CAPITAL FUNDING CORPORATION 3328 PEACHTREE ROAD, SUITE 150 ATLANTA GA GEORGIA 30326 Director ZENNIE W. LYNCH, JR. C/O RENASANT CAPITAL FUNDING CORPORATION 3328 PEACHTREE ROAD, SUITE 150 ATLANTA GA GEORGIA 30326 Executive Officer SUZANNE LONG 6224 SUGARLOAF PARKWAY SUITE 300 DULUTH GA GEORGIA 30097 Executive Officer REITS and Finance Decline to Disclose 06b false 2022-12-19 false true false 1000 WILLIAM A. MCGUGIN 5322620 ICA, LLC 145235 3100 WEST END AVENUE SUITE 910 NASHVILLE TN TENNESSEE 37203 FL FLORIDA TN TENNESSEE false MATTHEW B. JACQUES 5929189 ICA, LLC 145235 3100 WEST END AVENUE SUITE 910 NASHVILLE TN TENNESSEE 37203 FL FLORIDA TN TENNESSEE false 121000 121000 0 false 121 6050 0 0 false RENASANT CAPITAL FUNDING CORP /s/ Curtis J. Perry Curtis J. Perry President and Chief Executive Officer 2022-12-29